Datum Dental, Ltd. appears in FDA device records as the applicant for OSSIX Plus under premarket notification K262415, a traditional 510(k) reviewed by the Dental advisory committee with product code NPL. The record lists a decision of substantially equivalent dated October 29, 2026, following receipt on July 15, 2026. The filing address is given as 38 Hayarkon St., Yavne, Israel, which is a correspondence address in the filing rather than a verified corporate headquarters. Manufacturer documentation published by Dentsply Sirona identifies Datum Dental Ltd. at the same Yavne address as the device manufacturer, and the OSSIX Plus brand materials are published on Dentsply Sirona's regenerative solutions site. [1][2][6]
The documented product and its construction
OSSIX Plus is described in manufacturer instructions for use as a biodegradable and biocompatible collagen membrane intended for use during guided tissue and bone regeneration. The collagen is extracted from porcine tendons subjected to veterinarian inspection and purified to prevent hypersensitivity reactions. The device is packaged in a sealed double blister inside a cardboard box and is terminally sterilized by ethylene oxide. The same description appears in the US and Australia versions of the instructions for use, and the European-language version identifies Datum Dental Ltd. as the manufacturer. [2][8][6]
Brand materials published by Dentsply Sirona present OSSIX Plus as an ossifying collagen barrier membrane for guided bone regeneration and guided tissue regeneration, and associate it with GLYMATRIX technology. Those materials also state contraindications for patients with known collagen hypersensitivity, sensitivity to porcine-derived materials, or autoimmune and connective tissue diseases, and note that allergic reactions may not be entirely excluded given the collagen origin. [3][7]
Regulatory record and dated filing
The FDA 510(k) record for K262415 lists Datum Dental, Ltd. as applicant, OSSIX Plus as the device name, product code NPL, regulation number 872.3930, device class 2, and the openFDA device description barrier, animal source, intraoral, with a dental medical specialty. The decision code is SESE with the description substantially equivalent, the clearance type is traditional, the third-party flag is N, and the statement or summary field reads Summary. [1]
The linked collection for this company contains one 510(k) record, and that single record carries the SESE decision. The record sample is the same one entry, so the sample decision count is also one SESE. These figures describe the linked filings as retrieved on November 20, 2026, and do not represent total company sales, total portfolio or safety performance. [1]
Applicant, manufacturer and brand publisher
The FDA record names Datum Dental, Ltd. as the legal applicant, and the manufacturer documentation names Datum Dental Ltd. as the manufacturer at 38 Hayarkon St., Yavne 8122741, Israel. The OSSIX Plus instructions for use and brand pages are published by Dentsply Sirona, which appears in those documents as the European authorized representative context and importer, and the Australia version carries a Dentsply Sirona electronic instructions address. Trademark text in the Australia instructions attributes OSSIX marks to Datum Dental Ltd. and its affiliates or subsidiaries. No parent, owner or distributor relationship beyond these published roles is verified in the available records. [1][2][6][8]
What the record does not establish
The available records do not establish a corporate website, customer list, commercial availability, certification status or clinical outcome data for Datum Dental, Ltd. The FDA record's Yavne address is a filing address and is not treated here as a verified headquarters. The broader FDA 510(k) query result covering decisions from late October through December 2026 is a separate dataset and is not used to characterize this company's portfolio. [1][4]

